ProCE Banner Activity

Considerations for PrEP in Transgender Persons

Clinical Thought
Important considerations for PrEP in transgender individuals include choosing the right PrEP option and addressing stigma to improve adherence.

Released: April 15, 2022

Expiration: April 14, 2023

No longer available for credit.

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, and MSD.